Ingevity (NGVT) EBITDA (2015 - 2026)

Ingevity (NGVT) has 12 years of EBITDA data on file, last reported at $68.5 million in Q1 2026.

• EBITDA for Q1 2026 came in at $68.5 million, up 12.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $273.3 million (down 4.61% YoY), and the FY2025 annual result was $249.1 million, down 11.73% from the prior year.
• EBITDA climbed to $68.5 million in Q1 2026 per NGVT's latest filing, from $36.1 million in the prior quarter.
• Over five years, EBITDA peaked at $111.2 million in Q3 2022 and troughed at -$17.1 million in Q1 2024.
• A 5-year average of $63.4 million and a median of $71.1 million in 2023 frame the typical range for EBITDA.
• On a YoY basis, EBITDA climbed as much as 901.59% in 2024 and fell as far as 124.05% in 2024.
• A 5-year view of EBITDA shows it stood at $39.2 million in 2022, then slumped by 83.93% to $6.3 million in 2023, then jumped by 901.59% to $63.1 million in 2024, then tumbled by 42.79% to $36.1 million in 2025, then surged by 89.75% to $68.5 million in 2026.
• Business Quant data shows NGVT's EBITDA at $68.5 million in Q1 2026, $36.1 million in Q4 2025, and $82.8 million in Q3 2025.